These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33234771)

  • 21. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
    Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [
    Joo MK
    Korean J Gastroenterol; 2020 Nov; 76(5):227-231. PubMed ID: 33234768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
    Calvet X; Rue M
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1105-6. PubMed ID: 10930910
    [No Abstract]   [Full Text] [Related]  

  • 25. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS; McCloskey C; McSkimming P; McConnachie A
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-platelet therapy and managing ulcer risk.
    Chan FK
    J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose aspirin and comorbidities are significantly related to bleeding peptic ulcers in elderly patients compared with nonelderly patients in Japan.
    Higuchi T; Iwakiri R; Hara M; Shimoda R; Sakata Y; Nakayama A; Nio K; Yamaguchi S; Yamaguchi D; Watanabe A; Akutagawa T; Sakata H; Fujimoto K
    Intern Med; 2014; 53(5):367-73. PubMed ID: 24583422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Valkhoff VE; Sturkenboom MC; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.
    Kawamura N; Ito Y; Sasaki M; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
    BMC Res Notes; 2013 Nov; 6():455. PubMed ID: 24215903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic management of acute peptic ulcer bleeding.
    Lu Y; Chen YI; Barkun A
    Gastroenterol Clin North Am; 2014 Dec; 43(4):677-705. PubMed ID: 25440919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal management of peptic ulcer disease in the elderly.
    Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
    Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH; Bazzoli F
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?
    Sostres C; Lanas A
    Drugs; 2011 Jan; 71(1):1-10. PubMed ID: 21175237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
    Cullen DJ; Hawkey GM; Greenwood DC; Humphreys H; Shepherd V; Logan RF; Hawkey CJ
    Gut; 1997 Oct; 41(4):459-62. PubMed ID: 9391242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of H. pylori infection on upper gastrointestinal damage].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2010 Nov; 68(11):2020-4. PubMed ID: 21061526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
    Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.